Mini-Plenary Sessions
Tuesday, March 13
10:45am – 12:15pm
NANOTECHNOLOGY: The Path to Creating, Managing and Extracting Value from IP in Nanotechnology
This mini-plenary will explore the critical challenges that a company or university faces when commercializing nanotechnology IP, as the industry follows the path from early stage to maturity. The panel will focus on issues related to the prosecution, strategic use, valuation and licensing of nanotechnology IP. It will also cover topics related to nanotechnology investment, university-industry collaboration and environment health and safety.
Moderator:
Luca Escoffier, CEO, Usque Ad Sidera, LLC
Speakers:
- Lance Criscuolo, President, Zyvex Technologies
- Kenneth Epstein, Principal, NewCap Partners, Inc.
- Efrat Kasznik, Founder & President, Foresight Valuation Group, LLC
- Sarah Rouse, Patent Attorney, Katten Muchin Rosenman, LLP
10:45am – 12:15pm
WIRELESS MEDICAL DEVICES: Tomorrow’s Wireless Medical Devices: Overcoming Privacy Hurdles to Build a New Wireless Medical Infrastructure
This mini-plenary will focus on developments in the area of wireless medical monitoring devices, from a component and licensing perspective, from a privacy and software perspective (e.g., apps approved to store and review medical images; potential issues with wireless standards and medical instrumentation; privacy concerns; bioinformatics), and considering the challenges facing the market, ranging from health policy challenges to raising capital. The challenges and opportunities facing medical device instrumentation companies are a helpful example of the issues that arise when moving business functions or commercial operations to wireless mobile devices, regardless of the field or industry.
Monderator:
Adrian Mollo, Partner, McKenna Long & Aldridge, LLP
Panelists:
- Rel Ambrozy, McKenna Long & Aldridge, LLP
- Mark Chandler, CEO, SC Technology Advancement Organization, Managing Partner, Upstream Partners
- Geoff Hancock,
Director of Cloud, Security, Mobility and Healthcare, Verizon Federal
- Ellis Meng, Associate Professor of Biomedical Engineering, University of Southern California
Wednesday, March 14
10:45am – 12:15pm
CLEAN TECH: Creating & Maximizing the Value of IP in Clean Tech Transactions
This mini-plenary will examine the role that IP played in various recent Clean Tech transactions including through M&A, bankruptcy, asset sales and licensing and how the IP played in those transactions. Specifically, the panel will discuss what could be done to maximize value through building a more strategic portfolio and how the importance of the packaging of IP for typical business transactions has evolved from "nice to have" to "essential."
Moderator:
Ron Epperson, National Director, IP Services, McGladrey
Speakers:
- Stephen Compagni-Portis, Chairman and CEO, Renewable Funding LLC
- Joe Jennings, Founder, President/CEO, Drakes Bay Company
- Eric Lane, Special Counsel, Luce, Forward, Hamilton & Scripps
- Matt Rappaport, Co-Founder, Managing Director, IP Checkups
10:45am – 12:15pm
MEDICAL DEVICES: Roadmap to Creating Value: Perspectives from the Medical Device Industry
As the global economy shows signs of recovery, the health of the medical device industry has fared better than other industries. However, certain regulatory and financial developments will continue to place a strain on the industry. Most notably, the America Invents Act and how patent reform will impact medical device companies’ strategy of protection intellectual property. Companies will need to be nimble in embracing innovation in their business models and finding new methods to demonstrate product value. The panel of distinguished speakers will provide a roadmap for the path of successfully bringing medical devices to market.
Moderator:
Michael Rondelli, Director, Technology Transfer Office, San Diego State University Research Foundation
Panelists:
- Bill Becker, Senior Director, Intellectual Property, Align Technology, Inc.
- Howard J. Klein, Attorney, Klein, O'Neill & Singh, LLP
- Keith A. Newburry, Chief Intellectual Property Counsel, Edwards Lifesciences